Sex Differences in the Prevalence of Metabolic Syndrome and Its Components in Hypopituitary Patients: Comparison with an Age- and Sex-matched Nationwide Control Group

Overview

Journal Pituitary

Specialty Endocrinology

Date 2016 Sep 1

PMID 27577046

Citations 10

Authors

Ah Reum Khang

Eu Jeong Ku

Ye An Kim

Eun Roh

Jae Hyun Bae

Tae Jung Oh

Sang Wan Kim

Chan Soo Shin

Seong Yeon Kim

Jung Hee Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: Hypopituitary patients have a reduced life expectancy owing to cardiovascular events. We investigated the prevalence of metabolic syndrome in hypopituitary patients for a follow-up period of at least 1 year in comparison with an age- and sex-matched nationwide control group.

Methods: A total of 515 patients with hypopituitarism who visited Seoul National University Hospital between January 2000 and December 2010 were included. Data for an age- and sex-matched control group were obtained from the Korean National Health and Nutrition Examination Surveys (KNHANES) (n = 1545). Metabolic syndrome was defined according to the modified National Cholesterol Education Program (NCEP-ATPIII).

Results: The prevalence of metabolic syndrome did not differ significantly between the hypopituitary and control groups for men (34.9 versus 30.3 %), but the risk of metabolic syndrome was higher in hypopituitary women than in controls (39.8 versus 28.5 %). In both sexes, the risks of central obesity and dyslipidemia were higher in the hypopituitary group than in the control group. Men had lower risks of hypertension and hyperglycemia in the hypopituitary group, which attenuated the risk of metabolic syndrome. Age greater than 40 years and obesity (BMI ≥25 kg/m) contributed to a higher risk of metabolic syndrome.

Conclusions: The metabolic syndrome prevalence was higher in the hypopituitry group than in the control group in Korean women, and this was attributed to an increased risk of central obesity and dyslipidemia. Accordingly, early intervention to reduce metabolic syndrome needed in hypopituitary patients, i.e. women.

Citing Articles

Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality.

Donald D, McDonnell T, OReilly M, Sherlock M Rev Endocr Metab Disord. 2024; 25(5):839-854.

PMID: 39370498 PMC: 11470859. DOI: 10.1007/s11154-024-09897-7.

Growth Hormone Secretory Capacity Is Associated with Cardiac Morphology and Function in Overweight and Obese Patients: A Controlled, Cross-Sectional Study.

Gangitano E, Barbaro G, Susi M, Rossetti R, Spoltore M, Masi D Cells. 2022; 11(15).

PMID: 35954264 PMC: 9367721. DOI: 10.3390/cells11152420.

The association between dietary polyphenol intake and cardiometabolic factors in overweight and obese women: a cross-sectional study.

Aali Y, Ebrahimi S, Shiraseb F, Mirzaei K BMC Endocr Disord. 2022; 22(1):120.

PMID: 35538570 PMC: 9088119. DOI: 10.1186/s12902-022-01025-3.

Lipid profile and response to statin therapy in patients with hypopituitarism.

Rissetti G, Zeni D, Ongaratti B, Pereira-Lima J, Garcia Soares Leaes Rech C, Oliveira M Arch Endocrinol Metab. 2020; 64(6):673-678.

PMID: 33049128 PMC: 10528624. DOI: 10.20945/2359-3997000000292.

Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology.

Kim J, Chae H, Chin S, Ku C, Park K, Lim D Endocrinol Metab (Seoul). 2020; 35(2):272-287.

PMID: 32615711 PMC: 7386113. DOI: 10.3803/EnM.2020.35.2.272.

References

van der Klaauw A, Biermasz N, Feskens E, Bos M, Smit J, Roelfsema F . The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH. Eur J Endocrinol. 2007; 156(4):455-62. DOI: 10.1530/EJE-06-0699. View

Carr M . The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88(6):2404-11. DOI: 10.1210/jc.2003-030242. View

Ford E, Giles W, Mokdad A . Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004; 27(10):2444-9. DOI: 10.2337/diacare.27.10.2444. View

Baser O . Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health. 2006; 9(6):377-85. DOI: 10.1111/j.1524-4733.2006.00130.x. View

Rosen T, Bengtsson B . Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990; 336(8710):285-8. DOI: 10.1016/0140-6736(90)91812-o. View

Joffe M, Rosenbaum P . Invited commentary: propensity scores. Am J Epidemiol. 1999; 150(4):327-33. DOI: 10.1093/oxfordjournals.aje.a010011. View

Binnerts A, Deurenberg P, Swart G, Wilson J, Lamberts S . Body composition in growth hormone-deficient adults. Am J Clin Nutr. 1992; 55(5):918-23. DOI: 10.1093/ajcn/55.5.918. View

Abs R, Mattsson A, Thunander M, Verhelst J, Goth M, Wilton P . Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol. 2012; 168(3):297-305. DOI: 10.1530/EJE-12-0807. View

Regal M, Paramo C, Sierra S, Garcia-Mayor R . Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2002; 55(6):735-40. DOI: 10.1046/j.1365-2265.2001.01406.x. View

10.

Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

11.

Cuneo R, Salomon F, Watts G, Hesp R, Sonksen P . Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 1993; 42(12):1519-23. DOI: 10.1016/0026-0495(93)90145-e. View

12.

Beshyah S, Freemantle C, Thomas E, Rutherford O, Page B, Murphy M . Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf). 1995; 42(2):179-89. DOI: 10.1111/j.1365-2265.1995.tb01860.x. View

13.

de Boer H, Blok G, Voerman H, Phillips M, Schouten J . Serum lipid levels in growth hormone-deficient men. Metabolism. 1994; 43(2):199-203. DOI: 10.1016/0026-0495(94)90245-3. View

14.

Nielsen E, Lindholm J, Laurberg P . Excess mortality in women with pituitary disease: a meta-analysis. Clin Endocrinol (Oxf). 2007; 67(5):693-7. DOI: 10.1111/j.1365-2265.2007.02947.x. View

15.

Bulow B, Hagmar L, Eskilsson J, Erfurth E . Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab. 2000; 85(2):574-84. DOI: 10.1210/jcem.85.2.6346. View

16.

Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson B . Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 1993; 38(1):63-71. DOI: 10.1111/j.1365-2265.1993.tb00974.x. View

17.

Johansson J, Fowelin J, Landin K, Lager I, Bengtsson B . Growth hormone-deficient adults are insulin-resistant. Metabolism. 1995; 44(9):1126-9. DOI: 10.1016/0026-0495(95)90004-7. View

18.

Abs R, Feldt-Rasmussen U, Mattsson A, Monson J, Bengtsson B, Goth M . Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis. Eur J Endocrinol. 2006; 155(1):79-90. DOI: 10.1530/eje.1.02179. View

19.

Wuster C, Slenczka E, Ziegler R . [Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?]. Klin Wochenschr. 1991; 69(16):769-73. DOI: 10.1007/BF01797616. View

20.

Longobardi S, Cuocolo A, Merola B, Di Rella F, Colao A, Nicolai E . Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf). 1998; 48(2):137-43. DOI: 10.1046/j.1365-2265.1998.00281.x. View